Gut microbiome and incidence of major adverse cardiovascular events in the general population: a prospective study in five European cohorts
Background: Accumulating evidence suggests that the gut microbiota is implicated in cardiovascular disease. We investigated how the gut microbiome associates with incident major adverse cardiovascular events (MACE), and cardiovascular and all-cause mortality (ACM) in a large, prospective, population-based study. The findings were tested for replication in four independent cohorts. Methods: Gut microbiome composition was assessed via shallow shotgun sequencing in the FINRISK 2002 cohort, with up to 18 years of follow-up. Associations of microbial taxa with incident MACE were investigated using time-to-event analyses. Significant associated microbial features were tested for replication in four European cohorts (HUNT, HELIUS, SIMPLER, and SCAPIS) followed by a meta-analysis. Results: In the FINRISK 2002 cohort (1167 incident MACE events), nine taxa were significantly associated with incident MACE and sustained adjustments for traditional risk factors and multiple comparisons. The meta-analysis of replication cohorts (N=30,228; 1,938 participants with incident MACE) confirmed robust associations for several identified taxa. Specifically, higher abundance of genera Scardovia (HR=1.17 [95% CI 1.08-1.26], p= 0.0001) and Limosilactobacillus (HR=1.16 [95%CI 1.09-1.23], p= 1E-06) was associated with increased MACE risk, and increased risk of cardiovascular mortality and all-cause mortality. The species ER4 sp900317525 (HR=0.89 [95%CI 0.83-0.95], p=0.0005) was associated with lower hazard of MACE and all-cause mortality. Conclusions: The gut metagenome showed robust associations with incident MACE, which were replicated in four independent European cohorts. Key microbial taxa also associated with incident MACE and mortality, suggesting their potential relevance as candidate risk markers for further studies.
Authors
- Oleg Kambur
- Louise Grahnemo (ORCID: https://orcid.org/0000-0001-5276-6612)
- Tove Fall (ORCID: https://orcid.org/0000-0003-2071-5866)
- J. G. Smith (ORCID: https://orcid.org/0000-0003-0690-4396)
- Gunnar Engström (ORCID: https://orcid.org/0000-0002-8618-9152)
- Bert‐Jan H. van den Born (ORCID: https://orcid.org/0000-0003-0943-4393)
- Kristian Hveem (ORCID: https://orcid.org/0000-0001-8157-9744)
- Rob D. Knight (ORCID: https://orcid.org/0000-0002-0975-9019)
- Max Nieuwdorp (ORCID: https://orcid.org/0000-0002-1926-7659)
- Johan Ärnlöv (ORCID: https://orcid.org/0000-0002-6933-4637)
- Robert F. J. Kullberg (ORCID: https://orcid.org/0000-0001-8269-9887)
- Aki Samuli Havulinna (ORCID: https://orcid.org/0000-0002-4787-8959)
- Veikko V Salomaa (ORCID: https://orcid.org/0000-0001-7563-5324)
- Henrike Galenkamp (ORCID: https://orcid.org/0000-0002-5904-3465)
- Guillaume Méric (ORCID: https://orcid.org/0000-0001-6288-9958)
- Maria Nethander (ORCID: https://orcid.org/0000-0003-3688-906X)
- Marju Orho‐Melander (ORCID: https://orcid.org/0000-0002-3578-2503)
- Teemu Niiranen (ORCID: https://orcid.org/0000-0002-7394-7487)
- Kamalita Pertiwi (ORCID: https://orcid.org/0000-0003-2861-9051)
- Susanna C. Larsson (ORCID: https://orcid.org/0000-0003-0118-0341)
- Claes Ohlsson (ORCID: https://orcid.org/0000-0002-9633-2805)
- Koen Dekkers
- Kari Koponen
- Bastaan W. Haak
Institutions
- Uppsala University (SE)
- Baker Heart and Diabetes Institute (AU)
- University of Turku (FI)
- University of Eastern Finland (FI)
- Lund University (SE)
- Norwegian University of Science and Technology (NO)
- Karolinska Institutet (SE)
- University of California San Diego (US)
- Kuopio University Hospital (FI)
- Amsterdam University Medical Centers (NL)
- University of Gothenburg (SE)
- University of Amsterdam (NL)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-12
- DOI
- https://doi.org/10.64898/2026.11.10.26367787
- Primary Topic
- Gut microbiota and health
- Type
- preprint